*Result*: Spectrum analysis of inborn errors of metabolism for expanded newborn screening in Xinjiang, China.
JIMD Rep. 2022 Jan 27;63(2):146-161. (PMID: 35281663)
Mol Biol Rep. 2022 Nov;49(11):10409-10419. (PMID: 36104584)
Orphanet J Rare Dis. 2021 May 12;16(1):214. (PMID: 33980295)
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Jun 25;51(3):278-283. (PMID: 36207829)
Handb Clin Neurol. 2019;162:449-481. (PMID: 31324325)
J Hum Genet. 2011 Apr;56(4):306-12. (PMID: 21307867)
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 May 25;46(3):240-247. (PMID: 29039164)
Orphanet J Rare Dis. 2021 Apr 30;16(1):195. (PMID: 33931066)
BMC Pediatr. 2012 Feb 24;12:18. (PMID: 22364411)
Front Genet. 2022 Sep 30;13:801447. (PMID: 36246604)
Clin Chim Acta. 2020 Mar;502:133-138. (PMID: 31893530)
J Inherit Metab Dis. 2020 May;43(3):424-437. (PMID: 31828787)
J Med Screen. 2017 Mar;24(1):6-11. (PMID: 27252276)
Mol Genet Metab. 2013 Nov;110(3):241-7. (PMID: 23954310)
Zhonghua Er Ke Za Zhi. 2020 Jun 2;58(6):468-475. (PMID: 32521958)
Hum Mutat. 2003 Apr;21(4):345-56. (PMID: 12655544)
J Bioenerg Biomembr. 2011 Feb;43(1):39-46. (PMID: 21271280)
Int J Neonatal Screen. 2022 Aug 09;8(3):. (PMID: 35997437)
Mol Genet Metab. 2007 Jul;91(3):218-27. (PMID: 17502162)
Genet Med. 2015 May;17(5):405-24. (PMID: 25741868)
Ann Hum Genet. 2008 Nov;72(Pt 6):774-9. (PMID: 18798839)
Front Genet. 2022 Jan 12;12:763222. (PMID: 35095998)
Sci Rep. 2021 Jan 29;11(1):2699. (PMID: 33514801)
Front Genet. 2019 Jan 23;9:726. (PMID: 30728829)
J Pediatr Endocrinol Metab. 2020 May 26;33(5):639-645. (PMID: 32304307)
BMC Med Genet. 2018 Aug 29;19(1):154. (PMID: 30157807)
Mol Genet Metab. 2019 May;127(1):28-30. (PMID: 30928149)
*Further Information*
*To determine the disease spectrum and genetic characteristics of inborn errors of metabolism (IEM) in Xinjiang province in the northwest of China, 41,690 newborn babies were screening by tandem mass spectrometry from November 2018 to December 2021. Of these, 57 newborn babies were referred for genetic analysis by next-generation sequencing, which was validated by Sanger sequencing. A total of 36 newborn babies and one relative were diagnosed with IEM, and the overall positive predictive value was 29.03%. The overall incidence of IEM in Xinjiang was 1:1,158 (36/41,690). The incidence of amino acidemias, organic acidemias, and fatty acid oxidation disorder were 1:1,668 (25/41,690), 1:4,632 (9/41,690), and 1:20,845 (2/41,690), respectively. Phenylketonuria and methylmalonic acidemia were the two most common inborn errors of metabolism (IEM), accounting for 83% (30/36) of all confirmed cases. Some hotspot mutations were observed for several IEMs, including PAH gene c.158G > A (p.Arg53His) and c.688G > A (p.Val230Ile) for hyperphenylalaninemia. Four mutation types of the MMACHC gene (e.g., c.609G > A (p.Trp203Ter), c.567dupT (p.Ile190fs)) and six mutation types of the MMUT gene (e.g., c.729_730insT (p.Asp244fs)) were found for methylmalonic acidemia. We also found 11 mutations in six genes: PCCB, IVD, GCDH, MCCC1, SLC22A5, and ACADS in this region. This study combined tandem mass spectrometry and next-generation sequencing technology for the screening and diagnosis of IEM. The study provides effective clinical guidance, and the data provide a basis for expanding newborn screening, genetic screening, and IEM gene consultation in Xinjiang, China.
(© 2024 Zhu et al.)*
*The authors declare that they have no competing interests.*